Table 2 Comparison between studied groups regarding bacteremia and procalcitonin results (n = 99)
Group (I) | Group (II) | Group (III) | Test | P | ||||
|---|---|---|---|---|---|---|---|---|
Patient with first attack of bleeding (n = 35) | Patient with recurrent bleeding (n = 35) | Control patients (n = 29) | ||||||
No. | % | No. | % | No. | % | |||
Blood culture | ||||||||
Positive | 16 | 45.7% | 21 | 60% | 7 | 24.1% | χ2, 8.53 | 0.001 |
E.coli | 10 | 28.6% | 14 | 40% | 4 | 13.8% | ||
Staph. | 4 | 11.4% | 5 | 14.3% | 2 | 6.9% | ||
Klebseilla | 2 | 5.7% | 2 | 5.7% | 1 | 3.4% | ||
Negative | 19 | 54.3% | 14 | 40% | 22 | 75.9% | ||
Procalcitonin (ng/ml) | ||||||||
Positive | 15 | 42.9% | 21 | 60% | 6 | 20.7% | χ2, 10.0 | 0.006 |
Negative | 20 | 57.1% | 14 | 40% | 23 | 79.3% | ||
Procalcitonin (ng/ml), median (range) | 0.325 (0.12-2.8) | 1.92 (0.10-2.96) | 0.22 (0.11-2.19) | KW, 7.422 | 0.024 | |||